Interaction between noradrenergic and cholinergic signaling in amygdala regulates anxiety- and depression-related behaviors in mice.

Medications that target the noradrenergic system are important therapeutics for depression and anxiety disorders. More recently, clinical studies have shown that the α2-noradrenergic receptor (α2AR) agonist guanfacine can decrease stress-induced smoking relapse during acute abstinence, suggesting that targeting the noradrenergic system may aid in smoking cessation through effects on stress pathways in the brain. Acetylcholine (ACh), like the nicotine in tobacco, acts at nicotinic acetylcholine receptors (nAChRs) to regulate behaviors related to anxiety and depression.

Multiple Nicotinic Acetylcholine Receptor Subtypes in the Mouse Amygdala Regulate Affective Behaviors and Response to Social Stress.

Electrophysiological and neurochemical studies implicate cholinergic signaling in the basolateral amygdala (BLA) in behaviors related to stress. Both animal studies and human clinical trials suggest that drugs that alter nicotinic acetylcholine receptor (nAChR) activity can affect behaviors related to mood and anxiety. Clinical studies also suggest that abnormalities in cholinergic signaling are associated with major depressive disorder, whereas pre-clinical studies have implicated both β2 subunit-containing (β2*) and α7 nAChRs in the effects of nicotine in models of anxiety- and depression-like behaviors.

Modulation of aggressive behavior in mice by nicotinic receptor subtypes.

Aggression is frequently comorbid with neuropsychiatric conditions and is a predictor of worse outcomes, yet current pharmacotherapies are insufficient and have debilitating side effects, precluding broad use. Multiple models of aggression across species suggest that the nicotinic acetylcholine receptor (nAChR) agonist nicotine has anti-aggressive (serenic) properties. Here we demonstrate dose-dependent serenic effects of acute nicotine administration in three distinct mouse strains: C57BL/6, BALB/c, and CD1.

Factors influencing dairy calf and replacement heifer mortality in France.

Herd-level risk factors for dairy calf and heifer mortality in France were identified by calculating herd-level variables (including mortality risk or rate) using the National Bovine Identification Database (2005 and 2006). Eleven dairy production areas representing different livestock systems were also included. Statistical analyses were based on a probit model (mortality risk or rate=0 or >0) and a linear model (mortality risk or rate >0) corrected by the sample bias Heckman method.

Perinatal, neonatal, and rearing period mortality of dairy calves and replacement heifers in France.

Dairy calf and replacement heifer mortality in France was assessed by calculating mortality rates at 0 to 2d (calves), 3d to 1 mo (calves and heifers), 1 to 6 mo of age, and 6 mo of age to first calving (heifers) using the national identification database. Between birth and 2-d-old, 261,000 and 251,000 of the 3.56 and 3.